Ask OpenScientist

Ask a research question about Kearns-Sayre syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
4
Pathophys.
6
Phenotypes
10
Pathograph
1
Medical Actions
3
References
🏷

Classifications

🔗

Mappings

MONDO
MONDO:0010787 Kearns-Sayre syndrome
skos:exactMatch MONDO
Primary MONDO disease identifier for this Kearns-Sayre syndrome entry.
👪

Inheritance

1
Usually de novo mitochondrial inheritance HP:0001427
Kearns-Sayre syndrome is part of the single large-scale mitochondrial DNA deletion syndrome spectrum. Most cases are de novo, with rare maternal transmission possible when an affected mother carries a mtDNA deletion.
Mitochondrial inheritance
Show evidence (1 reference)
PMID:20301382 SUPPORT Other
"SLSMDSs are almost never inherited, suggesting that these disorders are typically caused by a de novo single large-scale mitochondrial DNA"
GeneReviews describes the SLSMD inheritance pattern as usually de novo.

Pathophysiology

4
Single Large-Scale mtDNA Deletion in Post-Mitotic Tissues
Kearns-Sayre syndrome is caused by a single large-scale deletion of mitochondrial DNA, usually sporadic and heteroplasmic. Deleted genomes are detected in affected tissues such as skeletal muscle; the proportion of deleted mtDNA, rather than a nuclear-gene defect, determines whether high-energy post-mitotic tissues cross the bioenergetic threshold.
mitochondrial DNA metabolic process GO:0032042 ⚠ ABNORMAL
Show evidence (2 references)
PMID:3412580 SUPPORT Human Clinical
"seven of seven patients with Kearns-Sayre syndrome (KSS)."
The foundational KSS study identified mtDNA deletions in all seven tested patients.
PMID:3412580 SUPPORT Human Clinical
"The deletions ranged in size from 2.0 to 7.0 kb"
This supports the large-scale variable-size deletion mechanism in KSS.
Mitochondrial Translation and OXPHOS Deficiency
The deleted mtDNA population reduces mitochondrial translation capacity and oxidative phosphorylation. The pathway product state is impaired ATP generation with lactate accumulation during cellular stress; clinical expression is strongest in extraocular muscle, retina, cardiac conduction tissue, and central nervous system.
mitochondrial translation GO:0032543 ↓ DECREASED oxidative phosphorylation GO:0006119 ↓ DECREASED aerobic respiration GO:0009060 ↓ DECREASED
Show evidence (1 reference)
PMID:25352051 SUPPORT Human Clinical
"Blood lactate was raised (>2.0"
This pediatric SLSMD cohort supports lactate elevation as a biochemical readout of respiratory-chain energy failure.
Ocular and Retinal Energy Failure
Extraocular muscle involvement produces ptosis and chronic progressive external ophthalmoplegia, while retinal energy failure produces pigmentary retinopathy. These findings define the core Kearns-Sayre phenotype.
Show evidence (2 references)
PMID:20301382 SUPPORT Other
"retinopathy, CPEO, and cardiac conduction abnormality."
GeneReviews names pigmentary retinopathy and CPEO as cardinal KSS features.
PMID:21165624 SUPPORT Human Clinical
"progressive external ophthalmoplegia, atypical retinitis pigmentosa and cardiac"
The clinical report summarizes the KSS triad, including PEO and retinal disease.
Cardiac Conduction and Neurologic Energy Failure
KSS energy failure extends to cardiac conduction tissue and central/auditory pathways. Conduction block can be life-threatening; neurologic involvement includes cerebellar ataxia, sensorineural hearing impairment, basal ganglia or white-matter lesions, and cognitive or endocrine complications in some patients.
Show evidence (2 references)
PMID:20301382 SUPPORT Other
"Additional features can include cerebellar ataxia, tremor, intellectual disability or cognitive decline,"
GeneReviews supports neurologic involvement beyond the cardinal ocular-retinal-cardiac triad.
PMID:21165624 SUPPORT Human Clinical
"life-threatening complications which can lead to sudden cardiac death."
This supports the clinical importance of cardiac conduction disease in KSS.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Kearns-Sayre syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

6
Ear 1
Sensorineural hearing impairment Sensorineural hearing impairment HP:0000407
Show evidence (1 reference)
PMID:25352051 SUPPORT Human Clinical
"Ten of 15 patients tested had sensorineural hearing loss"
The pediatric SLSMD cohort documents sensorineural hearing loss in tested patients.
Eye 2
Ptosis Ptosis HP:0000508
Show evidence (1 reference)
PMID:25352051 SUPPORT Human Clinical
"The most frequent neurological manifestation was ptosis, affecting 22 patients"
The pediatric SLSMD cohort documents ptosis as the most frequent neurologic manifestation.
Pigmentary retinopathy Pigmentary retinopathy HP:0000580
Show evidence (1 reference)
PMID:20301382 SUPPORT Other
"retinopathy, CPEO, and cardiac conduction abnormality."
GeneReviews includes pigmentary retinopathy in the defining KSS feature set.
Nervous System 1
Ataxia Ataxia HP:0001251
Show evidence (1 reference)
PMID:20301382 SUPPORT Other
"Additional features can include cerebellar ataxia, tremor, intellectual disability or cognitive decline,"
GeneReviews lists cerebellar ataxia among additional KSS features.
Other 2
Progressive external ophthalmoplegia Progressive external ophthalmoplegia HP:0000590
Show evidence (1 reference)
PMID:20301382 SUPPORT Other
"retinopathy, CPEO, and cardiac conduction abnormality."
GeneReviews includes CPEO in the defining KSS feature set.
Heart block Heart block HP:0012722
Show evidence (1 reference)
PMID:25352051 SUPPORT Human Clinical
"complete heart block in five"
The pediatric SLSMD cohort documents complete heart block in affected children.
💊

Medical Actions

1
Multidisciplinary surveillance and supportive care
Action: Supportive Care NCIT:C15747
Management is supportive and surveillance-focused, including cardiac conduction monitoring with pacing when indicated, neurologic and ophthalmologic care, hearing support, endocrine surveillance, nutrition and rehabilitation support, and avoidance of individualized mitochondrial-toxic medication risks.
Show evidence (2 references)
PMID:20301382 SUPPORT Other
"cardiac pacemaker in individuals with cardiac conduction block, with"
GeneReviews supports pacemaker consideration for KSS/SLSMD cardiac conduction block.
PMID:25352051 SUPPORT Human Clinical
"need for coordinated care of children with SLSMDs at a tertiary specialist centre."
The pediatric cohort supports coordinated multispecialty care for SLSMDs.
🔬

Biochemical Markers

1
Elevated lactate (INCREASED)
Show evidence (1 reference)
PMID:25352051 SUPPORT Human Clinical
"Blood lactate was raised (>2.0"
The pediatric SLSMD cohort supports elevated blood lactate as a biochemical readout.
{ }

Source YAML

click to show
name: Kearns-Sayre syndrome
creation_date: "2026-07-06T01:07:38Z"
category: Mendelian
synonyms:
- KSS
- Kearns Sayre Syndrome
description: >-
  Kearns-Sayre syndrome is a single large-scale mitochondrial DNA deletion
  syndrome with onset before age 20 years. The primary lesion is a heteroplasmic
  mtDNA deletion in post-mitotic tissues, especially skeletal and extraocular
  muscle, retina, cardiac conduction tissue, and central nervous system. The
  deletion compromises mitochondrial translation and respiratory-chain oxidative
  phosphorylation, producing chronic progressive external ophthalmoplegia,
  pigmentary retinopathy, and cardiac conduction disease, with frequent ataxia,
  hearing impairment, endocrine disease, and lactic-acid biochemical stress.
  It is modeled as a distinct disorder entry rather than a subtype of Pearson
  syndrome because it has its own MONDO/OMIM/Orphanet identity and a different
  tissue-dominant clinical mechanism; both entries are grouped under single
  large-scale mtDNA deletion disorders.
references:
- reference: PMID:20301382
  title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
  tags:
  - GeneReviews
- reference: PMID:3412580
  title: Deletions of mitochondrial DNA in Kearns-Sayre syndrome.
- reference: PMID:25352051
  title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
disease_term:
  preferred_term: Kearns-Sayre syndrome
  term:
    id: MONDO:0010787
    label: Kearns-Sayre syndrome
parents:
- mitochondrial disease
- progressive external ophthalmoplegia
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0010787
      label: Kearns-Sayre syndrome
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: Primary MONDO disease identifier for this Kearns-Sayre syndrome entry.
external_assertions:
- name: OMIM Kearns-Sayre syndrome record
  source: OMIM
  assertion_type: disease_record
  external_id: OMIM:530000
  url: https://omim.org/entry/530000
  description: OMIM phenotype record for Kearns-Sayre syndrome.
- name: Orphanet Kearns-Sayre syndrome record
  source: Orphanet
  assertion_type: structured_disease_record
  external_id: ORPHA:480
  url: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=480
  description: Orphanet structured disease record for Kearns-Sayre syndrome.
classifications:
  icimd_category:
  - classification_value: single_large_scale_mtdna_deletions
    notes: >-
      WP-015 seed 6.3.02.01. Kearns-Sayre syndrome is one of the ICIMD disorders
      associated with single large-scale mtDNA deletions.
inheritance:
- name: Usually de novo mitochondrial inheritance
  description: >-
    Kearns-Sayre syndrome is part of the single large-scale mitochondrial DNA
    deletion syndrome spectrum. Most cases are de novo, with rare maternal
    transmission possible when an affected mother carries a mtDNA deletion.
  inheritance_term:
    preferred_term: Mitochondrial inheritance
    term:
      id: HP:0001427
      label: Mitochondrial inheritance
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      SLSMDSs are almost never inherited, suggesting that these disorders are
      typically caused by a de novo single large-scale mitochondrial DNA
    explanation: GeneReviews describes the SLSMD inheritance pattern as usually de novo.
pathophysiology:
- name: Single Large-Scale mtDNA Deletion in Post-Mitotic Tissues
  description: >-
    Kearns-Sayre syndrome is caused by a single large-scale deletion of
    mitochondrial DNA, usually sporadic and heteroplasmic. Deleted genomes are
    detected in affected tissues such as skeletal muscle; the proportion of
    deleted mtDNA, rather than a nuclear-gene defect, determines whether
    high-energy post-mitotic tissues cross the bioenergetic threshold.
  role: trigger
  biological_processes:
  - preferred_term: mitochondrial DNA metabolic process
    term:
      id: GO:0032042
      label: mitochondrial DNA metabolic process
    modifier: ABNORMAL
  evidence:
  - reference: PMID:3412580
    reference_title: Deletions of mitochondrial DNA in Kearns-Sayre syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: seven of seven patients with Kearns-Sayre syndrome (KSS).
    explanation: The foundational KSS study identified mtDNA deletions in all seven tested patients.
  - reference: PMID:3412580
    reference_title: Deletions of mitochondrial DNA in Kearns-Sayre syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The deletions ranged in size from 2.0 to 7.0 kb
    explanation: This supports the large-scale variable-size deletion mechanism in KSS.
  downstream:
  - target: Mitochondrial Translation and OXPHOS Deficiency
    causal_link_type: DIRECT
    description: >-
      Deletion of mtDNA sequence reduces the mitochondrial gene products needed
      for respiratory-chain oxidative phosphorylation.
- name: Mitochondrial Translation and OXPHOS Deficiency
  conforms_to: "mitochondrial_dysfunction#Bioenergetic Decline and Oxidative Stress"
  description: >-
    The deleted mtDNA population reduces mitochondrial translation capacity and
    oxidative phosphorylation. The pathway product state is impaired ATP
    generation with lactate accumulation during cellular stress; clinical
    expression is strongest in extraocular muscle, retina, cardiac conduction
    tissue, and central nervous system.
  role: central_effector
  biological_processes:
  - preferred_term: mitochondrial translation
    term:
      id: GO:0032543
      label: mitochondrial translation
    modifier: DECREASED
  - preferred_term: oxidative phosphorylation
    term:
      id: GO:0006119
      label: oxidative phosphorylation
    modifier: DECREASED
  - preferred_term: aerobic respiration
    term:
      id: GO:0009060
      label: aerobic respiration
    modifier: DECREASED
  chemical_entities:
  - preferred_term: ATP
    term:
      id: CHEBI:15422
      label: ATP
    modifier: DECREASED
  - preferred_term: (S)-lactate
    term:
      id: CHEBI:16651
      label: (S)-lactate
    modifier: INCREASED
  evidence:
  - reference: PMID:25352051
    reference_title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Blood lactate was raised (>2.0
    explanation: This pediatric SLSMD cohort supports lactate elevation as a biochemical readout of respiratory-chain energy failure.
  downstream:
  - target: Ocular and Retinal Energy Failure
    causal_link_type: DIRECT
    description: >-
      Energy failure in extraocular muscle and retina produces CPEO/ptosis and
      pigmentary retinopathy.
  - target: Cardiac Conduction and Neurologic Energy Failure
    causal_link_type: DIRECT
    description: >-
      Energy failure in conduction tissue and neural structures produces heart
      block, ataxia, hearing impairment, and other multisystem KSS features.
- name: Ocular and Retinal Energy Failure
  description: >-
    Extraocular muscle involvement produces ptosis and chronic progressive
    external ophthalmoplegia, while retinal energy failure produces pigmentary
    retinopathy. These findings define the core Kearns-Sayre phenotype.
  role: consequence
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: retinopathy, CPEO, and cardiac conduction abnormality.
    explanation: GeneReviews names pigmentary retinopathy and CPEO as cardinal KSS features.
  - reference: PMID:21165624
    reference_title: "[Kearns-Sayre syndrome : a mitochondrial disease (OMIM #530000)]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: progressive external ophthalmoplegia, atypical retinitis pigmentosa and cardiac
    explanation: The clinical report summarizes the KSS triad, including PEO and retinal disease.
  downstream:
  - target: Progressive external ophthalmoplegia
    causal_link_type: DIRECT
  - target: Ptosis
    causal_link_type: DIRECT
  - target: Pigmentary retinopathy
    causal_link_type: DIRECT
- name: Cardiac Conduction and Neurologic Energy Failure
  description: >-
    KSS energy failure extends to cardiac conduction tissue and central/auditory
    pathways. Conduction block can be life-threatening; neurologic involvement
    includes cerebellar ataxia, sensorineural hearing impairment, basal ganglia
    or white-matter lesions, and cognitive or endocrine complications in some
    patients.
  role: consequence
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Additional features can include cerebellar ataxia, tremor, intellectual disability or cognitive decline,
    explanation: GeneReviews supports neurologic involvement beyond the cardinal ocular-retinal-cardiac triad.
  - reference: PMID:21165624
    reference_title: "[Kearns-Sayre syndrome : a mitochondrial disease (OMIM #530000)]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: life-threatening complications which can lead to sudden cardiac death.
    explanation: This supports the clinical importance of cardiac conduction disease in KSS.
  downstream:
  - target: Heart block
    causal_link_type: DIRECT
  - target: Ataxia
    causal_link_type: DIRECT
  - target: Sensorineural hearing impairment
    causal_link_type: DIRECT
phenotypes:
- name: Progressive external ophthalmoplegia
  category: Ophthalmologic
  description: Chronic progressive external ophthalmoplegia is a defining KSS feature.
  phenotype_term:
    preferred_term: Progressive external ophthalmoplegia
    term:
      id: HP:0000590
      label: Progressive external ophthalmoplegia
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: retinopathy, CPEO, and cardiac conduction abnormality.
    explanation: GeneReviews includes CPEO in the defining KSS feature set.
- name: Ptosis
  category: Ophthalmologic
  description: Ptosis can precede full ophthalmoplegia in childhood SLSMD presentations.
  phenotype_term:
    preferred_term: Ptosis
    term:
      id: HP:0000508
      label: Ptosis
  evidence:
  - reference: PMID:25352051
    reference_title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The most frequent neurological manifestation was ptosis, affecting 22 patients
    explanation: The pediatric SLSMD cohort documents ptosis as the most frequent neurologic manifestation.
- name: Pigmentary retinopathy
  category: Ophthalmologic
  description: Pigmentary retinal degeneration is part of the KSS diagnostic triad.
  phenotype_term:
    preferred_term: Pigmentary retinopathy
    term:
      id: HP:0000580
      label: Pigmentary retinopathy
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: retinopathy, CPEO, and cardiac conduction abnormality.
    explanation: GeneReviews includes pigmentary retinopathy in the defining KSS feature set.
- name: Heart block
  category: Cardiovascular
  description: Cardiac conduction disease can progress to complete heart block and sudden death risk.
  phenotype_term:
    preferred_term: Heart block
    term:
      id: HP:0012722
      label: Heart block
  evidence:
  - reference: PMID:25352051
    reference_title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: complete heart block in five
    explanation: The pediatric SLSMD cohort documents complete heart block in affected children.
- name: Ataxia
  category: Neurologic
  description: Cerebellar ataxia is a recognized additional KSS feature.
  phenotype_term:
    preferred_term: Ataxia
    term:
      id: HP:0001251
      label: Ataxia
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Additional features can include cerebellar ataxia, tremor, intellectual disability or cognitive decline,
    explanation: GeneReviews lists cerebellar ataxia among additional KSS features.
- name: Sensorineural hearing impairment
  category: Otolaryngologic
  description: Sensorineural hearing impairment is common in the KSS/SLSMD spectrum.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:25352051
    reference_title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Ten of 15 patients tested had sensorineural hearing loss
    explanation: The pediatric SLSMD cohort documents sensorineural hearing loss in tested patients.
biochemical:
- name: Elevated lactate
  presence: INCREASED
  biomarker_term:
    preferred_term: (S)-lactate
    term:
      id: CHEBI:16651
      label: (S)-lactate
  evidence:
  - reference: PMID:25352051
    reference_title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Blood lactate was raised (>2.0
    explanation: The pediatric SLSMD cohort supports elevated blood lactate as a biochemical readout.
diagnosis:
- name: Mitochondrial DNA deletion testing
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: MAXO:0000127
      label: genetic testing
  description: >-
    Molecular testing identifies a single large-scale mtDNA deletion. In
    children, blood or urine testing can often detect the deletion; adult cases
    may require skeletal muscle.
  results: Detection of a single large-scale mtDNA deletion supports Kearns-Sayre syndrome in the correct clinical setting.
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: (mtDNA) deletion ranging in size from 1.1 to 10 kb on molecular genetic testing.
    explanation: GeneReviews defines molecular testing for single large-scale mtDNA deletion syndromes.
treatments:
- name: Multidisciplinary surveillance and supportive care
  description: >-
    Management is supportive and surveillance-focused, including cardiac
    conduction monitoring with pacing when indicated, neurologic and
    ophthalmologic care, hearing support, endocrine surveillance, nutrition and
    rehabilitation support, and avoidance of individualized mitochondrial-toxic
    medication risks.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301382
    reference_title: Single Large-Scale Mitochondrial DNA Deletion Syndromes.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: cardiac pacemaker in individuals with cardiac conduction block, with
    explanation: GeneReviews supports pacemaker consideration for KSS/SLSMD cardiac conduction block.
  - reference: PMID:25352051
    reference_title: "Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: need for coordinated care of children with SLSMDs at a tertiary specialist centre.
    explanation: The pediatric cohort supports coordinated multispecialty care for SLSMDs.
notes: >-
  Scope decision: Kearns-Sayre syndrome is kept as a separate Disease entry
  because it has a distinct MONDO identity (MONDO:0010787; OMIM:530000;
  ORPHA:480) and a post-mitotic ocular-retinal-cardiac mechanism distinct from
  the infantile marrow-pancreas presentation of Pearson syndrome. The shared
  SLSMD mechanism is captured in the Single Large-Scale mtDNA Deletion Disorders
  grouping.
📚

References & Deep Research

References

3
Single Large-Scale Mitochondrial DNA Deletion Syndromes.
No top-level findings curated for this source.
Deletions of mitochondrial DNA in Kearns-Sayre syndrome.
No top-level findings curated for this source.
Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease.
No top-level findings curated for this source.